AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017
May 3, 2017
30339_dirs_2017-05-03_94e5a8a3-dcc6-4d55-a1a6-8b692e14d676.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-05-02
Reporting Person: ZENNER PATRICK J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-02 | Common Stock | A | 1697.00 | $0.00 | Acquired | 53328.5691 | Direct |
| 2017-05-02 | Common Stock | A | 528.00 | $0.00 | Acquired | 53856.5691 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Unit | $ | Common Stock (16347.8588) | 16347.8588 | Direct |
Footnotes
F1: These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
F3: This award vests in 4 equal quarterly installments beginning on 08/01/2017.
F4: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
F5: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.